April 23, 2017 |  SteadyMed Therapeutics, an Israeli medical company, raised $30 million in a private placement led by Adage Capital Management, OrbiMed, Deerfield Management and Kingdon Capital Management. SteadyMed  develops drug product candidates to treat orphan and high-value diseases with unmet delivery needs. The company was founded in 2005 in the Zisapel family’s RAD Biomed incubator. Headquartered in […]